about
Sex dimorphism and depot differences in adipose tissue functionA role for novel adipose tissue-secreted factors in obesity-related carcinogenesis.Serum omentin and vaspin levels in cirrhotic patients with and without portal vein thrombosisEffect of Body Mass Index on Posttonsillectomy HemorrhageOmentin changes following bariatric surgery and predictive links with biomarkers for risk of cardiovascular diseaseAssociation of circulating C1q/TNF-related protein 1 levels with coronary artery disease in men.Association of serum omentin levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: a hospital-based study.The effect of enteral nutrition on adipokines in patients with acute pancreatitis.Novel adipokines and bone metabolism.Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease.Association between omentin-1 expression in human epicardial adipose tissue and coronary atherosclerosis.Evaluation of the relationship between circulating omentin-1 concentrations and components of the metabolic syndrome in adults without type 2 diabetes or cardiovascular disease.Serum levels of omentin-1 are increased after weight loss and are particularly associated with increases in obese children with metabolic syndrome.Levels of metabolic markers in drug-naive prediabetic and type 2 diabetic patients.Adipose Tissue-Derived Omentin-1 Function and Regulation.Omentin attenuates atherosclerotic lesion formation in apolipoprotein E-deficient mice.Serum omentin-1, inflammation and carotid atherosclerosis in patients with non-diabetic chronic kidney disease.Melatonin Supplementation Lowers Oxidative Stress and Regulates Adipokines in Obese Patients on a Calorie-Restricted Diet.Population-based serum omentin-1 levels: paradoxical association with cardiometabolic disorders primarily in men.Counteractive effects of omentin-1 against atherogenesis†.Serum Omentin-1 in Psoriasis.
P2860
Q26999869-31149256-8B86-468F-8156-0423E8249ADFQ30384899-03FB8743-A236-4918-B29A-F671F8482050Q33572695-35B7AACE-4FD6-4787-B611-343B96510EBBQ33710451-46DCB700-A373-4E5C-ABC0-F6996EA225E6Q34079744-6FF14640-9D2E-49EA-A0AA-7DFCF1AB4431Q35190964-631ADB8E-EFD3-4A13-9732-8F2E70B78951Q36163654-FDA2DDE4-1330-4C8D-AE70-2192617CB2B7Q36177659-64CC3E4B-3DD2-4AB1-8D44-B520EFC51618Q36619316-1EE99FAA-FC1E-47E6-BEF6-B1082C9ACF57Q36951691-2F0B0DC2-6420-4124-8643-A0B524EF72EDQ37045241-74884DE6-7087-46DB-9F10-64F4960FCAA5Q37514552-8A6EFD97-3418-429E-8FE5-0C92685EA365Q38612064-9B9153E9-2D2C-42AB-8D26-84854FD5E93EQ38810169-1D2C932C-9BC0-4BA2-A09E-44DF5B65A989Q39390964-BA99D31A-69D3-4581-A7EA-348B0CBC7564Q40161032-FAA68E71-8167-4265-ADC1-3D7C64D1226DQ46074545-109510B4-B451-4547-9EB7-CC07A2BCA79FQ47096054-F9B929B8-90B8-4936-8269-A628013CC215Q50072128-6F18764F-F571-4D5D-A812-D9E1264BB44EQ53800814-FFC9D437-E7DD-46AC-99FD-4A7A40416A9EQ55252634-4EF09AA8-8CCB-4BDF-B5BE-21AA926388EE
P2860
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Omentin as a novel biomarker of metabolic risk factors.
@ast
Omentin as a novel biomarker of metabolic risk factors.
@en
type
label
Omentin as a novel biomarker of metabolic risk factors.
@ast
Omentin as a novel biomarker of metabolic risk factors.
@en
prefLabel
Omentin as a novel biomarker of metabolic risk factors.
@ast
Omentin as a novel biomarker of metabolic risk factors.
@en
P2093
P2860
P356
P1476
Omentin as a novel biomarker of metabolic risk factors.
@en
P2093
Akiko Higuchi
Hiroko Terasaki
Koji Ohashi
Nobuo Ikeda
Noriyuki Ouchi
Rei Shibata
Ryotaro Takahashi
Shinji Kihara
Toyoaki Murohara
Yuya Terakura
P2860
P2888
P356
10.1186/1758-5996-4-37
P577
2012-07-26T00:00:00Z
P5875
P6179
1038290107